On Friday, the US FDA announced that low amounts of chemicals linked to cancer have been discovered in the samples of Zantac, a heartburn medication.

The discovered chemical is a kind of impurity known as NDMA that has been related to an elevated risk for uterine and colorectal cancers.

According to the FDA, the low NDMA levels were discovered in the samples of a drug called ranitidine, which is utilized to prevent and treat heartburn by lowering stomach acid. It is sold in the country under the brand Zantac.

It isn’t known where the contamination really originated from. NDMA has previously also led to several blood pressure drug recalls last year.

Presently, the government hasn’t recalled Zantac or other medicines containing ranitidine.

The FDA informed that it is still analysing if the levels discovered in the antacids may have pose any health risk. Besides, it also said that people should stop consuming heartburn medication till the time more details are known.

The health officials from Europe said on Friday that they are also probing NDMA levels discovered in ranitidine.

The other heartburn medications in the market like Nexium, Prilosec and Prevacid comprise of distinct ingredients and aren’t included in this warning.


With more than 30 years of experience working as a business advisor, Daniel explored the life of entrepreneurship with the inception of The Stock Dork. His knack for aggregating crucial information has resulted in amazing, praiseworthy news articles for the website from the Business niche.


Please enter your comment!
Please enter your name here